Adtalem Global Education (NYSE:CVSA) SVP Douglas Beck Sells 9,615 Shares

Adtalem Global Education Inc. (NYSE:CVSA) SVP Douglas Beck sold 9,615 shares of the firm’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $127.03, for a total value of $1,221,393.45. Following the completion of the transaction, the senior vice president owned 38,159 shares in the company, valued at $4,847,337.77. The trade was a 20.13% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

Shares of CVSA stock opened at $128.28 on Wednesday. The company has a fifty day moving average price of $112.44. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. The stock has a market cap of $4.37 billion, a price-to-earnings ratio of 19.98, a P/E/G ratio of 1.08 and a beta of 0.63. Adtalem Global Education Inc. has a fifty-two week low of $86.97 and a fifty-two week high of $156.26.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings data on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. The company had revenue of $487.03 million for the quarter. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The company’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, equities analysts forecast that Adtalem Global Education Inc. will post 8.03 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CVSA. Barrington Research reiterated an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a report on Friday, April 17th. Zacks Research lowered Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 25th. Weiss Ratings began coverage on Adtalem Global Education in a report on Wednesday, February 25th. They set a “hold (c+)” rating on the stock. Truist Financial raised their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday. Finally, Wall Street Zen downgraded Adtalem Global Education from a “buy” rating to a “hold” rating in a research report on Saturday. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, Adtalem Global Education currently has an average rating of “Moderate Buy” and an average price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.